Filing Details
- Accession Number:
- 0001209191-22-009821
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-15 17:00:58
- Reporting Period:
- 2022-02-11
- Accepted Time:
- 2022-02-15 17:00:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1626199 | Alpine Immune Sciences Inc. | ALPN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341382 | N James Topper | C/O Frazier Healthcare Partners 601 Union Street, Suite 3200 Seattle WA 98101 | Yes | No | Yes | No | |
1365617 | J Patrick Heron | C/O Frazier Healthcare Partners 601 Union Street, Suite 3200 Seattle WA 98101 | No | No | Yes | No | |
1655827 | Frazier Life Sciences Viii, L.p. | C/O Frazier Healthcare Partners 601 Union Street, Suite 3200 Seattle WA 98101 | No | No | Yes | No | |
1698755 | Fhm Life Sciences Viii, L.p. | C/O Frazier Healthcare Partners 601 Union Street, Suite 3200 Seattle WA 98101 | No | No | Yes | No | |
1698823 | Fhm Life Sciences Viii, L.l.c. | C/O Frazier Healthcare Partners 601 Union Street, Suite 3200 Seattle WA 98101 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-02-11 | 112,665 | $7.10 | 1,484,115 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James N. Topper and Patrick J. Heron are the sole managing members of FHM LLC. Mr. Topper, Mr. Heron, FHM LP and FHM LLC disclaims beneficial ownership of the securities held by FLS LP except, to the extent of his or its pecuniary interest therein, if any.